Y-mAbs Therapeutics, Inc. (YMAB)
NASDAQ: YMAB · IEX Real-Time Price · USD
11.37
-0.46 (-3.89%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Y-mAbs Therapeutics Market Cap
Y-mAbs Therapeutics has a market cap or net worth of $498.95 million as of July 2, 2024. Its market cap has increased by 59.76% in one year.
Market Cap
498.95M
Enterprise Value
424.38M
1-Year Change
59.76%
Ranking
Category
Stock Price
$11.37
Market Cap Chart
Since September 21, 2018, Y-mAbs Therapeutics's market cap has decreased from $783.00M to $498.95M, a decrease of -36.28%. That is a compound annual growth rate of -7.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 519.10M | 74.49% |
| Dec 29, 2023 | 297.50M | 39.61% |
| Dec 30, 2022 | 213.10M | -69.88% |
| Dec 31, 2021 | 707.50M | -64.73% |
| Dec 31, 2020 | 2.01B | 61.56% |
| Dec 31, 2019 | 1.24B | 78.50% |
| Dec 31, 2018 | 695.50M | -11.17% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Applied Therapeutics | 533.63M |
| Adaptive Biotechnologies | 533.47M |
| SI-BONE | 532.78M |
| Third Harmonic Bio | 532.34M |
| Aveanna Healthcare Holdings | 530.97M |
| Entrada Therapeutics | 529.05M |
| Lexeo Therapeutics | 528.44M |
| Heron Therapeutics | 527.29M |